| Message: | Anti-Estrogen Steroids Fulvestrant 129453-61-8 For Cancer Treatment
Brief Introduction:
CAS: 129453-61-8
Synonyms:Faslodex AstraZeneca
Chemical Name: (7A, 17b)-7-[9-[(4, 4, 5, 5, 5-Pentafluoropentyl)sulfinyl]nonyl]estra-1, 3, 5(10)-triene-3, 17-diol
Molecular Fomular: C32H47F5O3S
Molecular Weight: 606.77
Density: 1.201 g/cm3
Melting Point: 104-106
Boiling Point: 674.8 at 760 mmHg
Appearance: White powder
Usage: Antineoplastic (hormonal)
Storage: Shading, confined preservation
Usage:Fulvestrant is a type of hormone treatment. It is also called Faslodex. It is a treatment for post menopausal women with advanced breast cancer.A novel steroidal estrogen antagonist reported to lack any partial agonist activity. Also used as an antineoplastic raw materials.
Description:
Fulvestrant is a drug treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy. It is an estrogen receptor antagonist with no agonist effects, which works both by down-regulating and by degrading the estrogen receptor. It is administered as a once-monthly injection. |
my account
